Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetMitogen-activated protein kinase 14
LigandBDBM50374618
Substrate/Competitorn/a
Meas. Tech.ChEMBL_469610 (CHEMBL934189)
IC50 4300±n/a nM
Citation Martin, MWNewcomb, JNunes, JJBoucher, CChai, LEpstein, LFFaust, TFlores, SGallant, PGore, AGu, YHsieh, FHuang, XKim, JLMiddleton, SMorgenstern, KOliveira-dos-Santos, APatel, VFPowers, DRose, PTudor, YTurci, SMWelcher, AAZack, DZhao, HZhu, LZhu, XGhiron, CErmann, MJohnston, DSaluste, CG Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. J Med Chem51:1637-48 (2008) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
Mitogen-activated protein kinase 14
Name:Mitogen-activated protein kinase 14
Synonyms:CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta
Type:Serine/threonine-protein kinase
Mol. Mass.:41286.76
Organism:Homo sapiens (Human)
Description:Q16539
Residue:360
Sequence:
MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50374618
n/a
NameBDBM50374618
Synonyms:CHEMBL408030
TypeSmall organic molecule
Emp. Form.C34H35N7O2
Mol. Mass.573.6874
SMILESCc1cccc(C)c1-n1c2nc3ccccc3n2c2nc(Nc3ccc(OCCCN4CCCCC4)cc3)ncc2c1=O |(29.92,5.51,;31.26,4.75,;32.58,5.52,;33.93,4.74,;33.92,3.2,;32.59,2.44,;32.58,.9,;31.26,3.21,;29.93,2.44,;29.92,.9,;31.06,-.14,;30.43,-1.54,;31.05,-2.94,;30.15,-4.18,;28.61,-4.01,;28,-2.61,;28.91,-1.37,;28.59,.13,;27.25,.9,;25.91,.12,;24.58,.89,;23.25,.13,;21.92,.9,;21.93,2.44,;20.6,3.21,;19.26,2.44,;17.93,3.21,;16.59,2.44,;15.26,3.21,;15.26,4.75,;16.59,5.52,;17.93,4.74,;19.26,5.51,;19.27,7.05,;17.93,7.82,;16.59,7.05,;19.26,.89,;20.6,.13,;24.59,2.44,;25.91,3.21,;27.25,2.45,;28.58,3.22,;28.58,4.76,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: